Stem Cells and Gene Therapy for Cartilage Repair

Abstract EN

Cartilage defects represent a common problem in orthopaedic practice.

Predisposing factors include traumas, inflammatory conditions, and biomechanics alterations.

Conservative management of cartilage defects often fails, and patients with this lesions may need surgical intervention.

Several treatment strategies have been proposed, although only surgery has been proved to be predictably effective.

Usually, in focal cartilage defects without a stable fibrocartilaginous repair tissue formed, surgeons try to promote a natural fibrocartilaginous response by using marrow stimulating techniques, such as microfracture, abrasion arthroplasty, and Pridie drilling, with the aim of reducing swelling and pain and improving joint function of the patients.

These procedures have demonstrated to be clinically useful and are usually considered as first-line treatment for focal cartilage defects.

However, fibrocartilage presents inferior mechanical and biochemical properties compared to normal hyaline articular cartilage, characterized by poor organization, significant amounts of collagen type I, and an increased susceptibility to injury, which ultimately leads to premature osteoarthritis (OA).

Therefore, the aim of future therapeutic strategies for articular cartilage regeneration is to obtain a hyaline-like cartilage repair tissue by transplantation of tissues or cells.

Further studies are required to clarify the role of gene therapy and mesenchimal stem cells for management of cartilage lesions.